DOCSLIB.ORG

Radiation Oncology: Innovative, New Technologies and Research Are Turning Heads P

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Radiation Oncology: Innovative, New Technologies and Research Are Turning Heads P The past reveals CT’s future — Murat Gungor of Siemens — p. 88 Your Industry Source for Health Care and Equipment Coverage October 2015 You will do more with your CT in 2016… Even with changing reimbursements and dose reduction rates, CT continues to dominate p. 56 In this issue Exclusive Q&As with: • Suzanne Richards, CEO of Orange County Global Medical Center p. 34 • Dr. Bruce Minsky, ASTRO president p. 40 Industry sector reports: • Radiation Oncology: Innovative, new technologies and research are turning heads p. 44 • Proton Therapy: The treatment goes mainstream p. 76 We Stand Behind Our Products For more than 100 years, we have focused on providing you with the highest quality products Our customer service and technical support teams are available 24 x 7 to assist you. Give us a call today at 800.238.3780. OEM Imaging Components | Grids | Replacement Tubes www. dunlee.com | www.smitroentgen.com The Only True Alternative to the OEM CT • MR • PET • NM Service • Systems • Parts 888-BCTECH1 (228-3241) www.BCTechnical.com Need to Lower Patient Doses? WEST PHYSICS is Down With That! WEST PHYSICS leads the industry in providing a turn-key Patient Dose Reduction Service that is fully compliant with the new Joint Commission imaging standards. Our radiation consultants will assess your policies, procedures, scan protocols, hardware, software and training – everything that affects patient dose – and help you to set up and manage a simple and effective patient radiation dose reduction program. Contact us today to find out www.westphysics.com/doseaudits how we can help your 1-866-275-WEST (9378) operation lower patient [email protected] doses while still delivering superb image quality! Need to Lower Patient Doses? CONTENTS WEST PHYSICS is Down With That! October 2015 THIS MONTH’S EXCLUSIVE Q&As 44 34 Suzanne Richards, CEO of Orange County Global Medical Center 40 Dr. Bruce Minsky, ASTRO president INDUSTRY SECTOR REPORTS 44 Radiation Oncology Innovative, new technologies and research are turning heads 56 CT No shortage of challenges in the CT market 70 X-ray Tubes 52 Industry experts offer their thoughts WEST PHYSICS leads the industry in providing a turn-key 76 Patient Dose Reduction Service that is fully compliant with the new Proton Therapy The treatment goes mainstream Joint Commission imaging standards. Our radiation consultants will assess your policies, procedures, scan protocols, hardware, software and training – everything that affects patient dose – and help you to set up and manage a simple and effective patient radiation dose reduction program. FEATURE 52 Radiation Shielding 76 Contact us today to find out www.westphysics.com/doseaudits There is more to proton shielding than meets the eye how we can help your 1-866-275-WEST (9378) Visit DOTmed.com/news for breaking news daily, to comment on stories in this operation lower patient [email protected] issue, to participate in surveys and more. doses while still delivering superb image quality! HealthCareBusiness news I OCTOBER 2015 3 䔀瘀攀爀礀琀栀椀渀最 戀甀琀 琀栀攀 戀愀戀礀 吀栀攀 䜀䔀 䌀漀爀漀洀攀琀爀椀挀猀 ㈀㔀㤀䌀 䘀攀琀愀氀 䴀漀渀椀琀漀爀 䌀愀戀氀攀猀 䤀渀挀氀甀搀攀搀 簀 ㄀㈀ 䴀漀渀琀栀 圀愀爀爀愀渀琀礀 簀 䤀渀 匀琀漀挀欀 一漀眀 嘀椀攀眀 漀甀爀 猀攀氀攀挀琀椀漀渀 漀昀 爀攀昀甀爀戀椀猀栀攀搀 昀攀琀愀氀 洀漀渀椀琀漀爀猀 漀渀氀椀渀攀 琀漀搀愀礀⸀ 㠀 ⸀㐀㐀㤀⸀㔀㌀㈀㠀 圀圀圀⸀倀䄀䌀䤀䘀䤀䌀䴀䔀䐀䤀䌀䄀䰀匀唀倀倀䰀夀⸀䌀伀䴀 ⌀倀䄀䌀䴀䔀䐀䰀䰀䌀 CONFERENCE & EXPO PREVIEW ASTRO 40 PUBLISHER DOTmed.com, Inc. PRESIDENT Philip F. Jacobus CHIEF TECHNOLOGY OFFICER Matt Ulman EXECUTIVE EDITOR Robert Garment EDITORIAL DIRECTOR Glenn J. Kalinoski 32 EDITORIAL CONTRIBUTING EDITOR Sean Ruck 212-742-1200 Ext. 218 [email protected] ONLINE EDITOR Gus Iversen STAFF WRITER Lauren Dubinsky CONTRIBUTING WRITERS Lisa Chamoff Michael Gray 34 40 Murat Gungor Tina Vatanka Murphy Jill Rathbun Bipin Thomas DESIGN COLUMNS DESIGN DIRECTOR Stephanie Biddle DESIGN CONSULTANT Oscar Polanco 6 Letter from the Editor SALES 7 Top Online Stories SALES DIRECTOR David Blumenthal 212-742-1200 Ext. 224 [email protected] 8 Letter from the Online Editor KEY ACCOUNT Susan Minotillo MANAGERS 212-742-1200 ext. 261 [email protected] 8 DOTmed Online News Connie Goon 212-742-1200 Ext. 289 31 Upcoming Events [email protected] ACCOUNT MANAGERS Colm Ford 212-742-1200 Ext. 241 32 Hospital Spotlight [email protected] Orange County Global Medical Center Troy Gladstone 212-742-1200 Ext. 246 35 Cost Containment Corner [email protected] Squeezing costs out of supply chain management Press Releases If you have news regarding your company submit it to: [email protected] 36 IT Matters Article and Story Consideration The significance of developing an enterprise imaging strategy If you have an article or feature story you would like the editor of HealthCare Business News to consider publishing, submit it to: [email protected] 38 New Products Showcase Letters to the Editor Submit letters to the editor to: [email protected] 43 View from the Hill Subscriptions For all subscription inquiries please email Congress focuses on imaging [email protected] or visit dotmed.com/magazine Auctions 51 Diagnostic Directions If you want information about auctioning equipment on DOTmed.com, please call: 212-742-1200 Ext. 296, Manufacturers are in the information business now or email us at [email protected] HealthCare Business News is published by DOTmed.com, Inc., 82 Medical Museum 29 Broadway, Suite 2500, New York, NY 10006 Copyright 2015 DOTmed.com, Inc. All rights reserved. 83 This Month in Medical History The father of emergency medicine, and Lyndon Johnson 88 The Future of Health Care DOTmedSM provides the HealthCare Business NewsSM to its registered The past reveals CT’s future users free of charge. DOTmedSM makes no warranty, representation or guarantee as to the accuracy or timeliness of its content. DOTmedSM may suspend or cancel this service at any time and for any reason without liability or obligation to any party. All trade names, trademarks and trade dress contained herein belong to their respective owners and are used herein with the intent to represent the goods and services of their respective owners. If you think your trade name, trademark or trade dress is not properly represented, please contact DOTmed.com, Inc. Letter from the Editor Back in the saddle again… Let’s flash back to early 2007… Now HealthCare Business News runs like a well-oiled machine, Imagine you’re now in lower Manhattan, up and the people on our news team have made it easy for me to get on the 25th floor in the conference room of back into my management position — this time as executive editor. a leading Internet company (aka DOTmed) We still have Sean Ruck as contributing editor, and the new kid on and a plan is being hatched: “Let’s create the block, Glenn Kalinoski — who joined us a few months ago — is a dynamic new print magazine focused on our editorial director. So we have plenty of managerial firepower to the underserved business end of the health go around. care industry.” “And let’s design it for the top And let me also mention Gus Iversen, our online news editor. He decision-makers in the industry.” “All in favor, say ‘aye.’” does a great job every day of finding and reporting on the top news And thus, our magazine was born. stories coming out of the health care industry. That’s why dotmed. The first issue rolled off the presses in April of that year, and the com/news should be a page you bookmark and visit every day. rest, as they say, is history. We also run the top online news stories from the past 30 days And now history repeats itself — after a fashion. in this magazine every month. In fact, those news highlights are so The original editor-in-chief of our original magazine was yours truly. informative, I call that section, “What You Need To Know.” Because I served ably in that capacity for almost a year and our magazine started if it’s news that the industry’s decision makers can’t do without, we to find its voice and audience. So much so, that we were soon able to make sure it’s available for everyone to read. turn over the reins to a new editor, while I returned to my other duties. So going forward, you will now see me penning the “Letter from Our publication continued to grow and prosper. We beefed up the Editor” each month, and behind the scenes I’ll be making sure the staff, improved the content, and under the long-term editorial that we put out a quality publication that is always worth your time leadership of Sean Ruck, we became an anchor publication in the to read from cover to cover. Now… “Giddyup!” health care industry. About two years ago we adopted the name, “HealthCare Business News” to accurately reflect that what we cover Robert Garment isn’t about DOTmed. It’s about what matters to you, to your career, Executive Editor and to our industry as a whole. [email protected] editorial advisory board Abass Alavi, MD, professor of Michael Friebe, PhD an affiliate Katie Regan, clinical publishing radiology and director of research professor at the Technical University manager, MD Buyline education in the Perelman School Munich in Germany of Medicine at the University of Bipin Thomas, chairman, ICURO Pennsylvania School of Medicine Heidi Horn, vice president of SSM Health Care’s Clinical Engineering Wayne Webster, principal, Leonard Arzt, executive director, Service (CES) department Proactics Consulting National Association for Proton Therapy Jason Launders, medical physicist, Sharon A. VanWicklin, MSN, RN, ECRI Institute CNOR/CRNFA, CPSN, PLNC, Norman E. Bolus, MSPH, MPH, perioperative nursing specialist, CNMT, editor-in-chief, JNMT, Jill Rathbun, president, Galileo Association of periOperative director, assistant professor Nuclear Consulting Group Inc. Registered Nurses (AORN) Medicine Technology Program Clinical & Diagnostic Sciences Department, Barbara G.
Load more

Recommended publications
  • Biomedical Engineering for Africa
    Biomedical Engineering for Africa Edited by Tania S. Douglas q Biomedical Engineering for Africa This work is licenced under the Creative Commons license: © The Authors Published in 2019 by University of Cape Town Libraries, Rondebosch, Cape Town, 7700, South Africa. Suggested citation: Douglas, T.S. Ed. 2019. Biomedical engineering for Africa. Cape Town: University of Cape Town Libraries. DOI: http://dx.doi.org/10.15641/0-7992-2544-0 Suggested citation of a chapter: Makobore, P.N. & Mulerwa, M. 2019. An electronically controlled gravity feed infusion set for intravenous fluids. In Biomedical engineering for Africa. T.S. Douglas, Ed. Cape Town: University of Cape Town Libraries. 125–138. DOI: http://dx.doi.org/10.15641/0-7992-2544-0 ISBN: 978-0-7992-2544-0 Contents List of Contributors v Foreword ix Folasade T. Ogunsola Chapter 1. Introduction 1 T.S. Douglas and R.L. Murphy Part 1. African Perspectives on Biomedical Engineering 5 Chapter 2. The Case for Biomedical Engineers in African Hospitals: A Clinician’s Point of View 7 D. Atwine Chapter 3. Recent Developments in Biomedical Engineering Education in Africa: A Focus on Nigeria and the University of Ibadan 11 A. Coker, F. Akintayo, C. Achi, M. Odeniyi, A. Olorunnisola and D. Akano Chapter 4. Creating a Department of Biomedical Engineering and an Undergraduate Programme – The University of Lagos Experience 19 O.P. Popoola, N.K. Irurhe, O.J. Balogun and A.A. Osuntoki Chapter 5. Biomedical Engineering in Ethiopia 27 A. Hussein and D. Assefa Part 2. From Needs to Products 33 Chapter 6. Biomedical Engineering and Entrepreneurship 35 C.J.
    [Show full text]
  • Patient Information Brochure
    2018/01/10 Dear Patient Welcome to our practice. We trust that you will find a supportive and caring environment with us. We would like to take the opportunity to introduce you to our staff, facilities, services and procedures with this brochure. STAFF Oncologists: We have six experienced specialists in our partnership: • Dr Rory Callaghan - The founding partner of the practice. He practices in Durban and Umhlanga, Ballito and in Hillcrest. Contact details: Office: 031-209 9030 (Durban), 031-350 4011 (Umhlanga), 031-350 4060 (Hillcrest) Cellular phone: 083-775 9154 email: [email protected] • Dr Leon Marais - He practices in Hillcrest and Durban. Contact details: Office: 031-209 9030 (Durban), 031-350 4060 (Hillcrest) Cellular phone: 083-636 6666 email: [email protected] • Dr Neil Narsai - He practices in Umhlanga and Durban. Contact details: Office: 031-209 9030 (Durban), 031-350 4011 (Umhlanga) Cellular phone: 081-016 4196 email: [email protected] • Dr Anne Maxwell - She practices in Durban. Contact details: Office: 031-209 9030 (Durban) Cellular phone: 083-789 5548 email: [email protected] • Dr Ria David – She practices in Durban and Umhlanga Contact details: Office: 031-209 9030 (Durban), 031-350 4011 (Umhlanga) Cellular phone: 083-682 0038 email: [email protected] • Dr Poovan Govender – He practices in Durban and Umhlanga Contact details: Office: 031-209 9030 (Durban), 031-350 4011 (Umhlanga) Cellular phone: 083-775 3255 email: [email protected] We value the relationship between us and our patients. Although you will mostly be seeing the same doctor, there will be times when the that doctor is not available.
    [Show full text]
  • Assessing Tumor Response and Detecting Recurrence in Metastatic Renal Cell Carcinoma on Targeted Therapy: Importance of Size and Attenuation on Contrast-Enhanced CT
    Genitourinary Imaging • Original Research Smith et al. Size and Attenuation of Metastatic RCC on CECT Genitourinary Imaging Original Research Assessing Tumor Response and Detecting Recurrence in Metastatic Renal Cell Carcinoma on Targeted Therapy: Importance of Size and Attenuation on Contrast-Enhanced CT Andrew Dennis Smith1 OBJECTIVE. The aim of this study was to improve response assessment in patients with Michael L. Lieber metastatic renal cell carcinoma (RCC) on antiangiogenic targeted therapy by evaluating Shetal N. Shah changes in both tumor size and attenuation and by detecting unique patterns of contrast en- hancement on contrast-enhanced CT (CECT). Smith AD, Lieber ML, Shah SN MATERIALS AND METHODS. Tumor long-axis measurements and volumetric mean tumor attenuation of target lesions on CECT images were correlated with time to progression in 53 patients with metastatic clear cell RCC treated with first-line sorafenib or sunitinib. The frequencies of specific patterns of tumor progression were assessed. The data were used to develop new imaging criteria, the size and attenuation CT (SACT) criteria. CECT findings were evaluated using the SACT criteria, Response Evaluation Criteria in Solid Tumors (RE- CIST), and modified Choi criteria, and the Kaplan-Meier method was used to estimate sur- vival functions. RESULTS. One or more target metastatic lesions had decreased attenuation of ≥ 40 HU in 59% of patients with progression-free survival of > 250 days (n = 44) after initiating targeted therapy; 0% of patients with earlier disease progression (n = 9) had this finding. A favorable response based on SACT criteria had a sensitivity of 75% and specificity of 100% for identify- ing patients with progression-free survival of > 250 days, versus 16% and 100%, respectively, for RECIST and 93% and 44% for the modified Choi criteria.
    [Show full text]
  • Europe's Beating Cancer Plan
    EUROPEAN COMMISSION Brussels, 3.2.2021 COM(2021) 44 final COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL Europe's Beating Cancer Plan {SWD(2021) 13 final} EN EN CONTENTS 1. A Cancer Plan for Europe: Introduction .................................................................................. 2 2. A modern approach to cancer: new technologies, research and innovation at the service of patient-centred cancer prevention and care ..................................................................................... 4 2.1. Driving change through knowledge and research ............................................................ 4 2.2. Making the most of data and digitalisation in cancer prevention and care ...................... 5 3. Saving lives through sustainable cancer prevention ................................................................ 7 3.1. Improving health literacy on cancer risks and determinants ............................................ 8 3.2. Achieving a tobacco-free Europe ..................................................................................... 8 3.3. Reducing harmful alcohol consumption .......................................................................... 9 3.4. Improving health promotion through access to healthy diets and physical activity ...... 10 3.5. Reducing environmental pollution ................................................................................. 11 3.6. Reducing exposure to hazardous substances and radiation ...........................................
    [Show full text]
  • Adolescent and Young Adult Cancer Survival Guide
    ADOLESCENT AND YOUNG ADULT CANCER SURVIVAL GUIDE FEATURING: LEONARD SENDER, MD & HEATHER HAWTHORNE, MD JUNE 2015 Watch the AYA Cancer Survival Guide Video INTRODUCTION The Hyundai Cancer Institute at CHOC Children’s Adolescent and Young Adult (AYA) Cancer Survival Guide Every year 70,000 young adults aged 15-39 are diagnosed with cancer in the United States alone. The CHOC Children’s Adolescent and Young Adult (AYA) Cancer Survival Guide Video and eBook are designed to help you face the challenges of your diagnosis, phase by phase. This CHOC Children’s AYA Cancer Survival Guide eBook supports you in setting measurable and achievable health goals, empowering you to become fully engaged in your journey from diagnosis to wellbeing. Whether you are a patient, caregiver or healthcare professional, this Survival Guide Video and eBook provide the expert insight, knowledge and information you need to make informed decisions. The Survival Guide eBook is interactive and serves as a creatively driven resource developed to help you, along with your family and support network as you engage with your doctors and healthcare providers. • Take your eBook with you to your appointments and treatments. • Use it to help you focus and optimize the treatment plan you elect to pursue. CHOC Children’s is dedicated to helping you survive and thrive. Thank you for selecting the CHOC Children’s AYA Cancer Survival Guide Video and eBook to accompany your journey from diagnosis to wellbeing. iii TABLE OF 1. Introduction CONTENTS 2. Advice for Using This AYA Cancer Survival Guide eBook 3. Dr. Leonard Sender, MD Introduction Introducing Dr.
    [Show full text]
  • Oncothermia Journal, May 2013 1
    2 A publication of Oncotherm June 2013 Volume 7 ISSN 2191-6438 OONNCCOOTTHHEERRMMIIAA JJOOUURRNNAALL Abstracts of the XXXI. Conference of the International Clinical Hyperhtermia Society (ICHS) Posters of the XXXI. Conference of the International Clinical Hyperthermia Society (ICHS) www.Oncothermia-Journal.comOncothermia Journal, May 2013 1 Editorial Dear Reader, at the end of last year we presented you a great variety of abstracts for talks and posters that were presented at the XXXI. Conference of the ICHS (International Clinical Hyperthermia Society) jointly held with the 2nd International Oncothermia Symposium. This large event – Oncotherm was the main sponsor -was held from October 12th-14th in Budapest, Hungary. Around 150 professors, doctors and experts from various disciplines came together representing 25 countries from all over the world in the beautiful Marriott Hotel, situated directly at the Danube. The proceedings of the conference with extended abstracts and some complete papers of the conference will be published in a peer-reviewed open-access journal: The „Conference Papers in Medicine“ very soon. In this issue of the Oncothermia Journal we are showing you the posters of the conference in the form as they were presented. New president and directors of ICHS were elected in Budapest. Prof. Dr. Clifford L.K. Pang became the new president and will host this year’s conference in Guangzhou, China from November 8th-10th, 2013. You can find more information about the ICHS and its structure in this magazine. We are pleased to learn about Oncotherm’s international success. However, our roots are in Germany. The smart German medical approach is still in our focus and is very important for the development of this method.
    [Show full text]
  • 2020-08-0852 TT ACF Onchronicle Newsletter 7.4Mb
    Issue 01 Vol 01 August 2020 OnChronicleC AN EXCLUSIVE NEWSLETTER OF ALAMELU CHARITABLE FOUNDATION, SUPPORTED BY TATA TRUSTS 1 Assam Cancer Care Foundation, a joint initiative of Government of Assam and Tata Trusts, is the Welcome most significant arm of the programme – with 10 under-construction hospitals and multiple operational projects, some of which are first of Note their kind. The state of Assam, which reports 32,000 new Dear Reader cancer cases every year, of which 70% of cases are reported in later stages, needed a structured We are delighted to bring you the first volume and early detection and screening programme. issue of ONCHRONICLE, the exclusive newsletter Through an MOU with National Health Mission of Alamelu Charitable Foundation (ACF), (NHM), capacity building, screening for early supported by Tata Trusts. detection and awareness programme has been launched in 8 districts. Opportunistic screening ACF was conceived and conceptualised by the kiosks have been opened up in 4 Medical College Tata Trusts in 2017, to mitigate the problems that Hospitals. ail cancer care in India. Since then it has been fighting against the lack of infrastructure and We have also entered into an understanding with trained workforce, deficient diagnostic and NHM in Maharashtra, Jharkhand, Andhra therapeutic medical equipment, limited financial Pradesh and Odisha and the capacity building, access, lack of cancer and palliative awareness, early detection and screening programmes are absence of quality care and more, while being rolled out in respective catchments. encouraging detection of cancer in its early stages. To provide the ease of access to cancer patients Content for chemotherapy and radiotherapy facilities, we To address these issues, the team is working at have introduced novel Day Care Centres.
    [Show full text]
  • Cancer Management During COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful Or Beneficial?
    cancers Review Cancer Management during COVID-19 Pandemic: Is Immune Checkpoint Inhibitors-Based Immunotherapy Harmful or Beneficial? Silvia Vivarelli 1, Luca Falzone 2,* , Caterina Maria Grillo 3, Giuseppa Scandurra 4, Francesco Torino 5 and Massimo Libra 1,6,* 1 Laboratory of Translational Oncology, Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy; [email protected] 2 Epidemiology Unit, IRCCS Istituto Nazionale Tumori ‘Fondazione G. Pascale’, I-80131 Naples, Italy 3 Otolaryngology Unit, Department of Medical Sciences, Surgical and Advanced Technologies, University of Catania, 95123 Catania, Italy; [email protected] 4 Medical Oncology Unit, Azienda Ospedaliera Cannizzaro, 95126 Catania, Italy; [email protected] 5 Department of Systems Medicine, Medical Oncology, University of Rome Tor Vergata, 00133 Rome, Italy; [email protected] 6 Research Center for Prevention, Diagnosis and Treatment of Cancer, University of Catania, 95123 Catania, Italy * Correspondence: [email protected] (L.F.); [email protected] (M.L.); Tel.: +39-320-1247-7937 (L.F.); +39-095-478-1271 (M.L.) Received: 8 July 2020; Accepted: 7 August 2020; Published: 10 August 2020 Abstract: The coronavirus disease 2019 (COVID-19) is currently representing a global health threat especially for fragile individuals, such as cancer patients. It was demonstrated that cancer patients have an increased risk of developing a worse symptomatology upon severe acute respiratory syndrome associated coronavirus-2 (SARS-CoV-2) infection, often leading to hospitalization and intensive care. The consequences of this pandemic for oncology are really heavy, as the entire healthcare system got reorganized. Both oncologists and cancer patients are experiencing rescheduling of treatments and disruptions of appointments with a concurrent surge of fear and stress.
    [Show full text]
  • What's Inside
    Newsletter A publication of the Controlled Release Society Volume 34 • Number 4 • 2017 What’s Inside Formulation of Monodisperse Non-Ionic Surfactant Vesicles (NISV) by Microfluidic Mixing Compared to Other Formulation Methods Electrospun Nanofibers for Localized Delivery of Dexamethasone: Preliminary Investigation on Formulation Parameters Controlled Release of Sex Pheromone from Ester Wax/ Polymer Bag Dispenser for Prevention of Grapholita molesta Interview with Arto Urtti Chapter News Newsletter Kenneth Carson Vol. 34 • No. 4 • 2017 Editor > TABLE OF CONTENTS 3 From the Editor 4 From the President Ryan Donnelly 5 2017 Awards & Recognition Editor 8 Interview A Focus on Ocular Delivery: Interview with Arto Urtti 11 Scientifically Speaking Formulation of Monodisperse Non-Ionic Surfactant Vesicles (NISV) by Microfluidic Mixing Compared to Other Formulation Methods Steven Giannos 14 Scientifically Speaking Editor Electrospun Nanofibers for Localized Delivery of Dexamethasone: Preliminary Investigation on Formulation Parameters 17 Scientifically Speaking Controlled Release of Sex Pheromone from Ester Wax/Polymer Bag Dispenser for Prevention of Grapholita molesta 21 Chapter News Medha Joshi Report on the First Joint CRS–CoRE-Net Industry-Academia Networking Day, Editor June 23, 2017 23 Chapter News CRS Nordic Chapter Meeting 25 DDTR Update Drug Delivery and Translational Research Update Arlene McDowell 27 People in the News Editor 29 Companies in the News > ADVERTISER INDEX 20 Millipore Sigma Bozena Michniak-Kohn Editor Cover image: Molecular structure of steroid Dexamethasone – synthetic steriod medication, 3D rendering Raimundo79 / Shutterstock.com Rod Walker Editor 2 > FROM THE EDITOR Editors Kenneth Carson Ryan Donnelly Medha Joshi Steven Giannos Midwestern University, Chicago College of Pharmacy Medha Joshi Downers Grove, IL, U.S.A.
    [Show full text]
  • Zimbabwe: Medical Treatment and Healthcare
    Country Policy and Information Note Zimbabwe: Medical treatment and healthcare Version 2.0 April 2021 Preface Purpose This note provides country of origin information (COI) for decision makers handling cases where a person claims that to remove them from the UK would be a breach of Articles 3 and/or 8 of the European Convention on Human Rights (ECHR) because of an ongoing health condition. It is not intended to be an exhaustive survey of healthcare in Zimbabwe. Country of origin information The country information in this note has been carefully selected in accordance with the general principles of COI research as set out in the Common EU [European Union] Guidelines for Processing Country of Origin Information (COI), dated April 2008, and the Austrian Centre for Country of Origin and Asylum Research and Documentation’s (ACCORD), Researching Country Origin Information – Training Manual, 2013. Namely, taking into account the COI’s relevance, reliability, accuracy, balance, currency, transparency and traceability. The structure and content of the country information section follows a terms of reference which sets out the general and specific topics relevant to this note. All information included in the note was published or made publicly available on or before the ‘cut-off’ date(s) in the country information section. Any event taking place or report/article published after these date(s) is not included. All information is publicly accessible or can be made publicly available, and is from generally reliable sources. Sources and the information they provide are carefully considered before inclusion. Factors relevant to the assessment of the reliability of sources and information include: x the motivation, purpose, knowledge and experience of the source x how the information was obtained, including specific methodologies used x the currency and detail of information, and x whether the COI is consistent with and/or corroborated by other sources.
    [Show full text]
  • Healthcare List of Medical Institutions Participating in Medisave Scheme Last Updated on 1 April 2020 by Central Provident Fund Board
    1 Healthcare List of Medical Institutions Participating in MediSave Scheme Last updated on 1 April 2020 by Central Provident Fund Board PUBLIC HOSPITALS/MEDICAL CLINICS Alexandra Hospital* Admiralty Medical Centre* Changi General Hospital* Institute of Mental Health Jurong Medical Centre* Khoo Teck Puat Hospital* KK Women's And Children's Hospital* National Cancer Centre National Dental Centre National Heart Centre Singapore National Skin Centre National University Hospital* Ng Teng Fong General Hospital* Singapore General Hospital* Singapore National Eye Centre Sengkang General Hospital* Tan Tock Seng Hospital* PRIVATE HOSPITALS/MEDICAL CLINICS Concord International Hospital Farrer Park Hospital Gleneagles Hospital* Mt Alvernia Hospital* Mt Elizabeth Hospital* Mount Elizabeth Novena Hospital Parkway East Hospital* Raffles Hospital Pte Ltd Starmed Specialist Centre Pte Ltd Thomson Medical Centre* PRIVATE CLINIC FOR OUTPATIENT HYPERBARIC OXYGEN THERAPY CLAIM Hyperbaric Medical Services DAY SURGERY CENTRES A Clinic For Women A Company For Women A L Lim Clinic For Women Pte Ltd Abraham’s Ear, Nose & Throat Surgery Pte Ltd Access Medical (Toa Payoh) Access Medical (Bukit Batok) Access Medical (East Coast) Access Medical (Kim Keat) Access Medical (Marine Terrace) Access Medical (Whampoa) Access Medical (Redhill Close) Access Medical (Tampines 730) Access Medical (Circuit Road) Access Medical (Bedok South) *These medical institutions also provide approved Hepatitis B, Pneumococcal and Human Papillomavirus (HPV) vaccinations to their patients.
    [Show full text]
  • Hospitalaria 2021 Mariola Sirvent-Ochando Et Al
    Farmacia Hospitalaria 2021 Mariola Sirvent-Ochando et al. l Vol. 45 l Nº 3 l 109 - 114 l 109 Farmacia HOSPITALARIA Órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria ORIGINALS Author of correspondence Bilingual edition English/Spanish Margarita Garrido Siles Autovía A-7, km 187 NUTRI-ONCOCARE: New integral nutrition care model 29603 Marbella (Málaga). Spain. to prevent and treat malnutrition in cancer patients Email: [email protected] NUTRI-ONCOCARE: Nuevo modelo integral de atención nutricional para prevenir y tratar la desnutrición en pacientes con cáncer Mariola Sirvent-Ochando1, Ana Murcia-López2, Cristina Sangrador-Pelluz3, Sara Esplá1, Margarita Garrido-Siles4, Jimena Abilés4 Received 1 July 2019; 1 2 Servicio de Farmacia Hospitalaria, Clínica Vistahermosa-HLA, Alicante. Spain. Servicio de Farmacia Hospitalaria, Hospital General Universitario de Elche, Elche Accepted 30 March 2020. (Alicante). Spain. 3Servicio de Farmacia Hospitalaria, Hospital Universitario Mutua Terrassa, Terrassa (Barcelona). Spain. 4Servicio de Farmacia y Nutrición, Hospital Costa del Sol, Málaga. Spain. DOI: 10.7399/fh.11299 How to cite this paper Sirvent-Ochando M, Murcia-López A, Sangrador-Pelluz C, Esplá S, Garrido-Siles M, Abilés J. NUTRI-ONCOCARE: New integral nutrition care model to prevent and treat malnutrition in cancer patients. Farm Hosp. 2021;45(3):109-14. Abstract Resumen Objective: The maximum expression of malnutrition in cancer patients Objetivo: La máxima expresión de la desnutrición en los pacientes is cancerous cachexia, always linked to an unfavorable prognosis. Given oncológicos es la caquexia cancerosa, siempre vinculada a un pronóstico its evolutionary nature it is recommended to detect and act early in those desfavorable.
    [Show full text]